Infant Powered Resuscitator Market

A medical device called an Infant Powered Resuscitator (IPR) is used to maintain a newborn's breathing when they are experiencing respiratory distress. The resuscitation bag must be manually compressed in order to give air to the patient's lungs while the machine is handled by hand. The IPR is a very important part of neonatal resuscitation because it is designed to give the baby a controlled flow of air and oxygen.

By 2031, the market for infant-powered resuscitators is anticipated to reach $** million, expanding at a CAGR of **% from 2018. Some of the biggest companies in the global IPR industry are Airon Corporation, Becton, Dickinson and Company, Bio-Med Devices, Inc., BLS Systems Limited, CareFusion Corporation, Fisher & Paykel Healthcare Limited, and Laerdal Medical.

Worldwide, there have been more premature births, which has increased the need for respiratory support equipment like IPR. For neonates that encounter respiratory distress at birth, neonatal resuscitation is crucial. Neonatal resuscitation is becoming more widely known, which is fueling the market for IPR devices.

IPR usage demands skilled personnel who can use the equipment properly. One of the biggest obstacles to the implementation of IPR devices is a shortage of competent workers and inadequate training. The strict and time-consuming regulatory procedures governing the production and distribution of IPR devices may limit their availability and use.

The market for infant-powered resuscitation is expected to grow significantly in the Asia-Pacific region over the next few years. Premature birth rates are rising, healthcare costs are rising, and people are becoming more aware of the importance of newborn care, among other things.